KE2808A - Tablet formulation - Google Patents

Tablet formulation

Info

Publication number
KE2808A
KE2808A KE2808A KE280878A KE2808A KE 2808 A KE2808 A KE 2808A KE 2808 A KE2808 A KE 2808A KE 280878 A KE280878 A KE 280878A KE 2808 A KE2808 A KE 2808A
Authority
KE
Kenya
Prior art keywords
tablet formulation
formulation
tablet
Prior art date
Application number
KE2808A
Inventor
A J Torode
D Harden
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of KE2808A publication Critical patent/KE2808A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KE2808A 1973-05-23 1974-12-02 Tablet formulation KE2808A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2462873A GB1460302A (en) 1973-05-23 1973-05-23 Tablet formulation

Publications (1)

Publication Number Publication Date
KE2808A true KE2808A (en) 1978-02-17

Family

ID=10214700

Family Applications (1)

Application Number Title Priority Date Filing Date
KE2808A KE2808A (en) 1973-05-23 1974-12-02 Tablet formulation

Country Status (21)

Country Link
JP (1) JPS577128B2 (en)
AT (1) AT351167B (en)
AU (1) AU469472B2 (en)
BE (1) BE815409A (en)
CA (1) CA977279A (en)
CY (1) CY941A (en)
DE (1) DE2424950A1 (en)
DK (1) DK144261C (en)
FI (1) FI156674A (en)
FR (1) FR2230341B1 (en)
GB (1) GB1460302A (en)
HK (1) HK1378A (en)
HU (1) HU170656B (en)
IE (1) IE39283B1 (en)
IL (1) IL44877A (en)
IT (1) IT8048966A0 (en)
KE (1) KE2808A (en)
MY (1) MY7800181A (en)
NL (1) NL190436C (en)
SE (1) SE402525C (en)
ZA (1) ZA743318B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
DE3839825A1 (en) * 1988-11-25 1990-06-13 Henning Berlin Gmbh SOLIDS DISPERSIONS CONTAIN OXIPURINOL AND / OR ITS ALKALI OR EARTH ALKALISALZE
EP0719547A1 (en) * 1994-07-18 1996-07-03 Luis Cipriano Carvajal Martin Self-desintegrating compact granules used in galenic forms and containing active insoluble or hardly soluble principles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors
US3624205A (en) * 1967-04-25 1971-11-30 Burroughs Wellcome Co Treatment of hyperuricemia in humans

Also Published As

Publication number Publication date
GB1460302A (en) 1977-01-06
JPS5040721A (en) 1975-04-14
AU469472B2 (en) 1976-02-12
ATA426774A (en) 1978-12-15
NL7406873A (en) 1974-11-26
DK144261B (en) 1982-02-01
AU6925274A (en) 1975-11-27
IE39283L (en) 1974-11-23
MY7800181A (en) 1978-12-31
DK144261C (en) 1991-02-04
BE815409A (en) 1974-11-22
FI156674A (en) 1974-11-24
IT8048966A0 (en) 1980-06-13
FR2230341A1 (en) 1974-12-20
DE2424950A1 (en) 1974-12-19
HK1378A (en) 1978-01-13
IL44877A0 (en) 1974-07-31
AT351167B (en) 1979-07-10
HU170656B (en) 1977-07-28
FR2230341B1 (en) 1977-04-15
CA977279A (en) 1975-11-04
SE402525C (en) 1982-09-15
NL190436B (en) 1993-10-01
IL44877A (en) 1976-11-30
CY941A (en) 1978-06-23
NL190436C (en) 1994-03-01
ZA743318B (en) 1975-05-28
JPS577128B2 (en) 1982-02-09
SE402525B (en) 1978-07-10
IE39283B1 (en) 1978-09-13

Similar Documents

Publication Publication Date Title
ZA743934B (en) Pharmaceutical compositions
AU7259274A (en) Medicaments
GB1368540A (en) Rinse-wax formulation
HK72578A (en) Pharmaceutical compositions
IL44646A0 (en) Novel pharmaceutical tablets
ZA744373B (en) Pharmaceutical compositions
AU7201374A (en) Pharmaceutical compositions
MW174A1 (en) Pharmaceutical formulation
ZA745756B (en) Pharmaceutical compositions
ZA744488B (en) Pharmaceutical compositions
AU6365873A (en) Bleaching formulation
KE2808A (en) Tablet formulation
CY1052A (en) Tablet formulation
AU7292674A (en) Biscuits
ZA747276B (en) Pharmaceutical compositions
ZA742064B (en) Pharmaceutical compositions
ZA746271B (en) Pharmaceutical compositions
AU7349374A (en) Medicinal composition
ZA743282B (en) Novel hormonic formulation
HK57578A (en) Pharmaceutical compositions
AU7044974A (en) Antihepatoxic substance
ZA741050B (en) Pharmaceutical compositions
ZA744243B (en) Pharmaceutical tablet
AU7274074A (en) Drug
AU5683073A (en) Sunshading devices sunshading devices